Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
Celebrating National Science Week / Q&A with Dr Ian Nisbet – Cartherics’ COO
By Christine Filippis / August 19, 2020
https://www.solubility.com.au/inspiringaustraliainitiative-4/ In celebration of National Science Week 2020, Solubility is supporting the#InspiringAustraliaInitiative by profiling five dynamic scientific careers. Next up...
Read More
Good News from Cartherics
By Christine Filippis / August 19, 2020
New funding from the Federal Entrepreneurs Programme will boost the company’s R&D efforts By Leigh Dayton “It’s good to get...
Read More
Cartherics attends international meeting of cell therapy leaders – virtually.
By Christine Filippis / July 8, 2020
Join a panel on “off-the-shelf” therapies with CEO Alan Trounson By Leigh Dayton 8 July 2020 Cartherics will take part...
Read More
